Neuromodulation is a re-emerging part of the treatment for the management of chronic pain disorders. At the same time, the importance of appropriately indicated lesioning procedures remains understated. Data from well-designed trials appears promising and hopes to provide insight into appropriate target selection. This session will discuss innovative targeting for the treatment of chronic pain, explore potential mechanisms of action, and discuss high-yield case presentations.
CME Credits: 1.5 AMA PRA Category 1 CreditsTM
Upon completion of this educational activity, participants should be able to:
- Describe when lesioning versus stimulation is appropriate to manage chronic pain.
- Explain the difference between cancer versus non-cancer pain and nuances involved in treatment.
- Discuss the current literature and evidence to aid in target selection for treatment of pain.
Michael D. Staudt, MD, MSc
Rushna P. Ali, MD
Stimulation vs. Lesioning: Target Selection, Current Evidence, and Practice Parameters for Management of Cancer Pain
Amitabh Gulati, MD
Tailoring DBS for Chronic Pain
Prasad Shirvalkar, MD,PHD
Case Discussions 1: Lesioning vs. Stimulation for Long-Term Management of Cancer Pain
Ahmed Raslan, MD
Case Discussions 2: Lesioning vs. Stimulation for Long-Term Management of Non-Cancer Pain
Konstantin V. Slavin, MD
Faculty and Presentations subject to change.